BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15923078)

  • 1. Molecular mechanism of HMGA1 deregulation in human neuroblastoma.
    Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Gulino A
    Cancer Lett; 2005 Oct; 228(1-2):97-104. PubMed ID: 15923078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
    Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
    Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
    Brocher J; Vogel B; Hock R
    BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA molecules in neuroblastic tumors.
    Cerignoli F; Ambrosi C; Mellone M; Assimi I; di Marcotullio L; Gulino A; Giannini G
    Ann N Y Acad Sci; 2004 Dec; 1028():122-32. PubMed ID: 15650238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nucleotide excision repair by high mobility group protein HMGA1.
    Adair JE; Kwon Y; Dement GA; Smerdon MJ; Reeves R
    J Biol Chem; 2005 Sep; 280(37):32184-92. PubMed ID: 16033759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HMGA proteins: a myriad of functions (Review).
    Cleynen I; Van de Ven WJ
    Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
    Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
    Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
    Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
    Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
    Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
    Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group A1 and cancer: potential biomarker and therapeutic target.
    Shah SN; Resar LM
    Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
    Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
    BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas.
    Pierantoni GM; Battista S; Pentimalli F; Fedele M; Visone R; Federico A; Santoro M; Viglietto G; Fusco A
    Carcinogenesis; 2003 Dec; 24(12):1861-9. PubMed ID: 12970064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of HMGA1 to changes in oxygen availability is evolutionarily conserved.
    Moussavi Nik SH; Newman M; Lardelli M
    Exp Cell Res; 2011 Jul; 317(11):1503-12. PubMed ID: 21530505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
    Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
    Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1-dependent and independent 7SK RNA gene regulatory activity.
    Eilebrecht S; Bécavin C; Léger H; Benecke BJ; Benecke A
    RNA Biol; 2011; 8(1):143-57. PubMed ID: 21282977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.
    Akhter MZ; Rajeswari MR
    J Photochem Photobiol B; 2014 Dec; 141():36-46. PubMed ID: 25313540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.